Section 5: Dialysis Interventions for Treatment of AKI

Kidney International Supplements

Volumn 2, Issue 1, 2012, Pages 89-115

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85085280370     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2011.35     Document Type: Article

References (269)

1. Liano, F., Pascual, J., Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 50 (1996), 811–818.
2. Bouchard, J., Soroko, S.B., Chertow, G.M., et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 76 (2009), 422–427.
3. Payen, D., de Pont, A.C., Sakr, Y., et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care, 12, 2008, R74.
4. van der Voort, P.H., Boerma, E.C., Koopmans, M., et al. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. Crit Care Med 37 (2009), 533–538.
5. Uchino, S., Bellomo, R., Morimatsu, H., et al. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med 37 (2009), 2576–2582.
6. Nash, K., Hafeez, A., Hou, S., Hospital-acquired renal insufficiency. Am J Kidney Dis 39 (2002), 930–936.
7. Kellum, J.A., Mehta, R.L., Levin, A., et al. Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi process. Clin J Am Soc Nephrol 3 (2008), 887–894.
8. Palevsky, P.M., Baldwin, I., Davenport, A., et al. Renal replacement therapy and the kidney: minimizing the impact of renal replacement therapy on recovery of acute renal failure. Curr Opin Crit Care 11 (2005), 548–554.
9. Allon, M., Shanklin, N., Effect of albuterol treatment on subsequent dialytic potassium removal. Am J Kidney Dis 26 (1995), 607–613.
10. Gauthier, P.M., Szerlip, H.M., Metabolic acidosis in the intensive care unit. Crit Care Clin 18 (2002), 289–308.
11. Kraut, J.A., Kurtz, I., Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol 3 (2008), 208–225.
12. Pearlman, B.L., Gambhir, R., Salicylate intoxicati on: a clinical review. Postgrad Med 121 (2009), 162–168.
13. Tyagi, P.K., Winchester, J.F., Feinfeld, D.A., Extracorporeal removal of toxins. Kidney Int 74 (2008), 1231–1233.
14. Bouman, C.S., Oudemans-Van Straaten, H.M., Tijssen, J.G., et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30 (2002), 2205–2211.
15. Conger, J.D., A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J Trauma 15 (1975), 1056–1063.
16. Fischer, R.P., Griffen, W.O. Jr, Reiser, M., et al. Early dialysis in the treatment of acute renal failure. Surg Gynecol Obstet 123 (1966), 1019–1023.
17. Kleinknecht, D., Jungers, P., Chanard, J., et al. Uremic and non-uremic complicat ions in acute renal failure: Evaluation of early and frequent dialysis on prognosis. Kidney Int 1 (1972), 190–196.
18. Parsons, F.M., Hobson, S.M., Blagg, C.R., et al. Optimum time for dialysis in acute reversible renal failure. Description and value of an improved dialyser with large surface area. Lancet 1 (1961), 129–134.
19. Gettings, L.G., Reynolds, H.N., Scalea, T., Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med 25 (1999), 805–813.
20. Demirkilic, U., Kuralay, E., Yenicesu, M., et al. Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg 19 (2004), 17–20.
21. Elahi, M.M., Lim, M.Y., Joseph, R.N., et al. Early hemofiltrati on improves survival in post-cardiotomy patients with acute renal failure. Eur J Cardiothorac Surg 26 (2004), 1027–1031.
22. Liu, K.D., Himmelfarb, J., Paganini, E., et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 1 (2006), 915–919.
23. Bagshaw, S.M., Uchino, S., Bellomo, R., et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 24 (2009), 129–140.
24. Shiao, C.C., Wu, V.C., Li, W.Y., et al. Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery. Crit Care, 13, 2009, R171.
25. Brandstrup, B., Tonnesen, H., Beier-Holgersen, R., et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 238 (2003), 641–648.
26. Foland, J.A., Fortenberry, J.D., Warshaw, B.L., et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med 32 (2004), 1771–1776.
27. Gillespie, R.S., Seidel, K., Symons, J.M., Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol 19 (2004), 1394–1399.
28. Goldstein, S.L., Currier, H., Graf, C., et al. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 107 (2001), 1309–1312.
29. Goldstein, S.L., Somers, M.J., Baum, M.A., et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 67 (2005), 653–658.
30. Hayes, L.W., Oster, R.A., Tofil, N.M., et al. Outcomes of critically ill children requiring continuous renal replacement therapy. J Crit Care 24 (2009), 394–400.
31. Sutherland, S.M., Zappitelli, M., Alexander, S.R., et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 55 (2010), 316–325.
32. Wiedemann, H.P., Wheeler, A.P., Bernard, G.R., et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354 (2006), 2564–2575.
33. Mehta, R.L., McDonald, B., Pahl, M., et al. Continuous vs. intermittent dialysis for acute renal failure in the ICU: Results from a randomized multicenter trial (abstract). J Am Soc Nephrol, 7, 1996, 1456.
34. Cruz, D.N., de Cal, M., Garzotto, F., et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 36 (2010), 444–451.
35. Hui-Stickle, S., Brewer, E.D., Goldstein, S.L., Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45 (2005), 96–101.
36. Williams, D.M., Sreedhar, S.S., Mickell, J.J., et al. Acute kidney failure: a pediatric experience over 20 years. Arch Pediatr Adolesc Med 156 (2002), 893–900.
37. Picca, S., Dionisi-Vici, C., Abeni, D., et al. Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol 16 (2001), 862–867.
38. Proulx, F., Fayon, M., Farrell, C.A., et al. Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest 109 (1996), 1033–1037.
39. Proulx, F., Gauthier, M., Nadeau, D., et al. Timing and predictors of death in pediatric patients with multiple organ system failure. Crit Care Med 22 (1994), 1025–1031.
40. Picca, S., Bartuli, A., Dionisi-Vici, C., Medical management and dialysis therapy for the infant with an inborn error of metabolism. Semin Nephrol 28 (2008), 477–480.
41. Picca, S., Ricci, Z., Picardo, S., Acute kidney injury in an infant after cardiopulmonary bypass. Semin Nephrol 28 (2008), 470–476.
42. Michael, M., Kuehnle, I., Goldstein, S.L., Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol 19 (2004), 91–95.
43. Goldstein, S.L., Advances in pediatric renal replacement therapy for acute kidney injury. Semin Dial 24 (2011), 187–191.
44. Bagshaw, S.M., Mortis, G., Godinez-Luna, T., et al. Renal recovery after severe acute renal failure. Int J Artif Organs 29 (2006), 1023–1030.
45. Bellomo, R., Cass, A., Cole, L., et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361 (2009), 1627–1638.
46. Palevsky, P.M., Zhang, J.H., O'Connor, T.Z., et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359 (2008), 7–20.
47. Prendergast, T.J., Luce, J.M., Increasing incidence of withholding and withdrawal of life support from the critically ill. Am J Respir Crit Care Med 155 (1997), 15–20.
48. Swartz, R., Perry, E., Daley, J., The frequency of withdrawal from acute care is impacted by severe acute renal failure. J Palliat Med 7 (2004), 676–682.
49. Ho, K.M., Liang, J., Hughes, T., et al. Withholding and withdrawal of therapy in patients with acute renal injury: a retrospective cohort study. Anaesth Intensive Care 31 (2003), 509–513.
50. Shealy, C.B., Campbell, R.C., Hey, J.C., et al. 24-hr creatinine clearance as a guide for CRRT withdrawal: a retrospective study (abstr). Blood Purif, 21, 2003, 192.
51. Wu, V.C., Ko, W.J., Chang, H.W., et al. Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy. Intensive Care Med 34 (2008), 101–108.
52. Askenazi, D.J., Feig, D.I., Graham, N.M., et al. 3–5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 69 (2006), 184–189.
53. Symons, J.M., Chua, A.N., Somers, M.J., et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2 (2007), 732–738.
54. Schetz, M., Anticoagulation in continuous renal replacement therapy. Contrib Nephrol 132 (2001), 283–303.
55. Bellomo, R., Parkin, G., Love, J., et al. Use of continuous haemodiafiltration: an approach to the management of acute renal failure in the critically ill. Am J Nephrol 12 (1992), 240–245.
56. Morabito, S., Guzzo, I., Solazzo, A., et al. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding. J Nephrol 16 (2003), 566–571.
57. Tan, H.K., Baldwin, I., Bellomo, R., Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 26 (2000), 1652–1657.
58. Uchino, S., Fealy, N., Baldwin, I., et al. Continuous venovenous hemofiltration without anticoagulation. ASAIO J 50 (2004), 76–80.
59. Agarwal, B., Shaw, S., Hari, M.S., et al. Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different?. J Hepatol 51 (2009), 504–509.
60. Davies, H., Leslie, G., Maintaining the CRRT circuit: non-anticoagulant alternatives. Aust Crit Care 19 (2006), 133–138.
61. Joannidis, M., Oudemans-van Straaten, H.M., Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care, 11, 2007, 218.
62. davenport, A., Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology (Carlton) 14 (2009), 455–461.
63. Hirsh, J., Bauer, K.A., Donati, M.B., et al. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008), 141S–159S.
64. Warkent in, T.E., Greinacher, A., Koster, A., et al. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008), 340S–380S.
65. Baglin, T., Barrowcliffe, T.W., Cohen, A., et al. Guidelines on the use and monitoring of heparin. Br J Haematol 133 (2006), 19–34.
66. Gray, E., Mulloy, B., Barrowcliffe, T.W., Heparin and low-molecular-weight heparin. Thromb Haemost 99 (2008), 807–818.
67. Martel, N., Lee, J., Wells, P.S., Risk for heparin-induced thrombocytopenia with unfraction ated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 106 (2005), 2710–2715.
68. Davenport, A., Tolwani, A., Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. NDT Plus 2 (2009), 439–447.
69. Lim, W., Cook, D.J., Crowther, M.A., Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials. J Am Soc Nephrol 15 (2004), 3192–3206.
70. European Best Practice Guidelines for Haemodialysis (Part 1). V. Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system., 17(Suppl 7), 2002, 63–71.
71. Fi scher, K.G., Essentials of anticoagulation in hemodialysis. Hemodial Int 11 (2007), 178–189.
72. Ouseph, R., Ward, R.A., Anticoagulation for intermittent hemodialysis. Semin Dial 13 (2000), 181–187.
73. Lim, W., Dentali, F., Eikelboom, J.W., et al. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 144 (2006), 673–684.
74. Akizawa, T., Koshikawa, S., Ota, K., et al. Nafamostat mesilate: a regional anticoagulant for hemodialysis in patients at high risk for bleeding. Nephron 64 (1993), 376–381.
75. Matsuo, T., Kario, K., Nakao, K., et al. Anticoagulation with nafamostat mesilate, a synthetic protease inhibitor, in hemodialysis patients with a bleeding risk. Haemostasis 23 (1993), 135–141.
76. Yang, J.W., Han, B.G., Kim, B.R., et al. Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage. Ren Fail 31 (2009), 668–675.
77. Maruyama, H., Miyakawa, Y., Gejyo, F., et al. Anaphylactoid reaction induced by nafamostat mesilate in a hemodialysis patient. Nephron 74 (1996), 468–469.
78. Muto, S., Imai, M., Asano, Y., Mechanisms of hyperkalemia caused by nafamostat mesilate. Gen Pharmacol 26 (1995), 1627–1632.
79. Okada, H., Suzuki, H., Deguchi, N., et al. Agranulocytosis in a haemodialysed patient induced by a proteinase inhibitor, nafamostate mesilate. Nephrol Dial Transplant, 7, 1992, 980.
80. Novacek, G., Kapiotis, S., Jilma, B., et al. Enhanced blood coagulation and enhanced fibrinolysis during hemodialysis with prostacyclin. Thromb Res 88 (1997), 283–290.
81. Swartz, R.D., Flamenbaum, W., Dubrow, A., et al. Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complications. J Clin Pharmacol 28 (1988), 818–825.
82. Monchi, M., Berghmans, D., Ledoux, D., et al. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 30 (2004), 260–265.
83. Kutsogiannis, D.J., Gibney, R.T., Stollery, D., et al. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 67 (2005), 2361–2367.
84. Betjes, M.G., van Oosterom, D., van Agteren, M., et al. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding. J Nephrol 20 (2007), 602–608.
85. Hetzel, G.R., Schmitz, Wissing, H., et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 26 (2011), 232–239.
86. Park, J.S., Kim, G.H., Kang, C.M., et al. Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoin g continuous venovenous hemodiafiltration. Korean J Intern Med 26 (2011), 68–75.
87. Fealy, N., Baldwin, I., Johnstone, M., et al. A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration. Int J Artif Organs 30 (2007), 301–307.
88. Oudemans-van Straaten, H.M., Bosman, R.J., Koopmans, M., et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 37 (2009), 545–552.
89. Mehta, R.L., McDonald, B.R., Aguilar, M.M., et al. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38 (1990), 976–981.
90. Morgera, S., Scholle, C., Voss, G., et al. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron Clin Pract 97 (2004), c131–c136.
91. Thoenen, M., Schmid, E.R., Binswanger, U., et al. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. Wien Klin Wochenschr 114 (2002), 108–114.
92. Uchino, S., Bellomo, R., Morimatsu, H., et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 33 (2007), 1563–1570.
93. Apsner, R., Schwarzenhofer, M., Derfler, K., et al. Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr 109 (1997), 123–127.
94. Durao, M.S., Monte, J.C., Batista, M.C., et al. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury. Crit Care Med 36 (2008), 3024–3029.
95. Kramer, L., Bauer, E., Joukhadar, C., et al. Citrate pharmacoki netics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 31 (2003), 2450–2455.
96. Hetzel, G.R., Taskaya, G., Sucker, C., et al. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis 48 (2006), 806–811.
97. Meier-Kriesche, H.U., Gitomer, J., Finkel, K., et al. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulati on. Crit Care Med 29 (2001), 748–752.
98. Bakker, A.J., Boerma, E.C., Keidel, H., et al. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Clin Chem Lab Med 44 (2006), 962–966.
99. Davies, H.T., Leslie, G., Pereira, S.M., et al. A randomized comparative crossover study to assess the affect on circuit life of varying pre-dilution volume associated with CVVH and CVVHDF. Int J Artif Organs 31 (2008), 221–227.
100. Holt, A.W., Bierer, P., Bersten, A.D., et al. Continuous renal replacement therapy in critically ill patients: monitoring circuit function. Anaesth Intensive Care 24 (1996), 423–429.
101. Joannidis, M., Kountchev, J., Rauchenzauner, M., et al. Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study. Intensive Care Med 33 (2007), 1571–1579.
102. Stefanidis, I., Hagel, J., Frank, D., et al. Hemostatic alterations during continuous venovenous hemofiltration in acute renal failure. Clin Nephrol 46 (1996), 199–205.
103. van de Wetering, J., Westendorp, R.G., van der Hoeven, J.G., et al. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 7 (1996), 145–150.
104. Yang, R.L., Liu, D.W., Clinical evaluation of hemofiltration without anticoagulation in critically ill patients at high risk of bleeding]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 29 (2007), 651–655.
105. Reeves, J.H., Cumming, A.R., Gallagher, L., et al. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Crit Care Med 27 (1999), 2224–2228.
106. de Pont, A.C., Oudemans-van Straaten, H.M., Roozendaal, K.J., et al. Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study. Crit Care Med 28 (2000), 421–425.
107. Birnbaum, J., Spies, C.D., Klotz, E., et al. Iloprost for additional anticoagulation in continuous renal replacement therapy–a pilot study. Ren Fail 29 (2007), 271–277.
108. Kozek-Langenecker, S.A., Spiss, C.K., Gamsjager, T., et al. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial. Wien Klin Wochenschr 114 (2002), 96–101.
109. Fabbri, L.P., Nucera, M., Al Malyan, M., et al. Regional anticoagulation and antiaggregation for CVVH in critically ill patients: a prospective, randomized, controlled pilot study. Acta Anaesthesiol Scand 54 (2010), 92–97.
110. Fiaccadori, E., Maggiore, U., Rotelli, C., et al. Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent. Intensive Care Med 28 (2002), 586–593.
111. Langenecker, S.A., Felfernig, M., Werba, A., et al. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. Crit Care Med 22 (1994), 1774–1781.
112. Biancofi ore, G., Esposito, M., Bindi, L., et al. Regional filter heparinizati on for continuous veno-venous hemofiltration in liver transplant recipients. Minerva Anestesiol 69 (2003), 527–534 534–528.
113. Kaplan, A.A., Petrillo, R., Regional heparinizati on for continuous arterio-venous hemofiltration (CAVH). ASAIO Trans 33 (1987), 312–315.
114. Carr, J.A., Silverman, N., The heparin-protamine interaction. A review. J Cardiovasc Surg (Torino) 40 (1999), 659–666.
115. Lasocki, S., Piednoir, P., Ajzenberg, N., et al. Anti-PF4/heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study. Crit Care, 12, 2008, R84.
116. Lo, G.K., Juhl, D., Warkentin, T.E., et al. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 4 (2006), 759–765.
117. O'Shea, S.I., Ortel, T.L., Kovalik, E.C., Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia. Semin Dial 16 (2003), 61–67.
118. Davenport, A., Anticoagulation options for patients with heparin-induced thrombocytopenia requiring renal support in the intensive care unit. Contrib Nephrol 156 (2007), 259–266.
119. Hursting, M.J., Murray, P.T., Argatroban anticoagulati on in renal dysfunction: a literature analysis. Nephron Clin Pract 109 (2008), c80–c94.
120. Link, A., Girndt, M., Selejan, S., et al. Argatroban for anticoagulation in continuous renal replacement therapy. Crit Care Med 37 (2009), 105–110.
121. Brophy, P.D., Somers, M.J., Baum, M.A., et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 20 (2005), 1416–1421.
122. Bunchman, T.E., Maxvold, N.J., Barnett, J., et al. Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol 17 (2002), 150–154.
123. Bunchman, T.E., Maxvold, N.J., Brophy, P.D., Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis 42 (2003), 1248–1252.
124. Klouche, K., Amigues, L., Deleuze, S., et al. Complications, effects on dialysis dose, and survival of tunneled femoral dialysis catheters in acute renal failure. Am J Kidney Dis 49 (2007), 99–108.
125. National Kidney Foundation, KDOQI clinical practice guidelines and clinical practice recommen dations for 2006 updates: vascular access. Am J Kidney Dis 48 (2006), S176–S307.
126. O'Grady, N.P., Alexander, M., Dellinger, E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 23 (2002), 759–769.
127. Leblanc, M., Fedak, S., Mokris, G., et al. Blood recirculat ion in temporary central catheters for acute hemodialysis. Clin Nephrol 45 (1996), 315–319.
128. Little, M.A., Conlon, P.J., Walshe, J.J., Access recirculation in temporary hemodialysis catheters as measured by the saline dilution technique. Am J Kidney Dis 36 (2000), 1135–1139.
129. Oliver, M.J., Acute dialysis catheters. Semin Dial 14 (2001), 432–435.
130. Twardowski, Z.J., History of peritoneal access development. Int J Artif Organs 29 (2006), 2–40.
131. Ronco, C., Dell'Aquila, R., Peritoneal access for acute peritoneal dialysis. Critical Care Nephrology, 2009, Saunders Elsevier, Philadelphia, PA, 1467–1471 In: Ronco C, Bellomo R, Kellum J (eds)., 2nd Edn.
132. Asif, A., Byers, P., Vieira, C.F., et al. Peritoneoscopic placement of peritoneal dialysis catheter and bowel perforation: experience of an interventional nephrology program. Am J Kidney Dis 42 (2003), 1270–1274.
133. Maya, I.D., Ultrasound/fluoroscopy-assisted placement of peritoneal dialysis catheters. Semin Dial 20 (2007), 611–615.
134. Schmidt, S.C., Pohle, C., Langrehr, J.M., et al. Laparoscopic-assisted placement of peritoneal dialysis catheters: implantation technique and results. J Laparoendosc Adv Surg Tech A 17 (2007), 596–599.
135. Cimochowski, G.E., Worley, E., Rutherford, W.E., et al. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 54 (1990), 154–161.
136. Schillinger, F., Schillinger, D., Montagnac, R., et al. Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavi an and 50 internal jugular accesses. Nephrol Dial Transplant 6 (1991), 722–724.
137. Oguzkurt, L., Tercan, F., Torun, D., et al. Impact of short-term hemodialysi s catheters on the central veins: a catheter venographic study. Eur J Radiol 52 (2004), 293–299.
138. Taal, M.W., Chesterton, L.J., McIntyre, C.W., Venography at insertion of tunnelled internal jugular vein dialysis catheters reveals significant occult stenosis. Nephrol Dial Transplant 19 (2004), 1542–1545.
139. Agarwal, A.K., Patel, B.M., Haddad, N.J., Central vein stenosis: a nephrologist's perspective. Semin Dial 20 (2007), 53–62.
140. Puel, V., Caudry, M., Le Metayer, P., et al. Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer 72 (1993), 2248–2252.
141. Yevzlin, A.S., Hemodialysis catheter-associated central venous stenosis. Semin Dial 21 (2008), 522–527.
142. Pronovost, P., Interventions to decrease catheter-related bloodstream infections in the ICU: the Keystone Intensive Care Unit Project. Am J Infect Control, 36, 2008, S171 e171 S171 e175.
143. Parienti, J.J., Thirion, M., Megarbane, B., et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 299 (2008), 2413–2422.
144. Hryszko, T., Brzosko, S., Mazerska, M., et al. Risk factors of nontunneled noncuffed hemodialysis catheter malfunction. A prospective study. Nephron Clin Pract 96 (2004), c43–c47.
145. Liangos, O., Rao, M., Ruthazer, R., et al. Factors associated with urea reduction ratio in acute renal failure. Artif Organs 28 (2004), 1076–1081.
146. Naumovic, R.T., Jovanovic, D.B., Djukanovic, L.J., Temporary vascular catheters for hemodialysis: a 3-year prospective study. Int J Artif Organs 27 (2004), 848–854.
147. Oliver, M.J., Edwards, L.J., Treleaven, D.J., et al. Randomized study of temporary hemodialysis catheters. Int J Artif Organs 25 (2002), 40–44.
148. Parienti, J.J., Megarbane, B., Fischer, M.O., et al. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med 38 (2010), 1118–1125.
149. Marschall, J., Mermel, L.A., Classen, D., et al. Strategies to prevent central line-associ ated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 29:Suppl 1 (2008), S22–S30.
150. Pratt, R.J., Pellowe, C.M., Wilson, J.A., et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 65:Suppl 1 (2007), S1–64.
151. Kusminsky, R.E., Complications of central venous catheterization. J Am Coll Surg 204 (2007), 681–696.
152. McGee, D.C., Gould, M.K., Preventing complications of central venous catheterization. N Engl J Med 348 (2003), 1123–1133.
153. Hind, D., Calvert, N., McWilliams, R., et al. Ultrason ic locating devices for central venous cannulation: meta-analysis. BMJ, 327, 2003, 361.
154. Randolph, A.G., Cook, D.J., Gonzales, C.A., et al. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med 24 (1996), 2053–2058.
155. Karakitsos, D., Labropoulos, N., De Groot, E., et al. Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care, 10, 2006, R162.
156. Leung, J., Duffy, M., Finckh, A., Real-time ultrasonographically-guided internal jugular vein catheterization in the emergency department increases success rates and reduces complication s: a randomized, prospective study. Ann Emerg Med 48 (2006), 540–547.
157. Bansal, R., Agarwal, S.K., Tiwari, S.C., et al. A prospective randomized study to compare ultrasound-guided with nonultrasound-guided double lumen internal jugular catheter insertion as a temporary hemodialysis access. Ren Fail 27 (2005), 561–564.
158. Farrell, J., Gellens, M., Ultrasound-guided cannulation versus the landmark-guided technique for acute haemodialysis access. Nephrol Dial Transplant 12 (1997), 1234–1237.
159. Gallieni, M., Central vein catheterization of dialysis patients with real time ultrasound guidance. J Vasc Access 1 (2000), 10–14.
160. Kwon, T.H., Kim, Y.L., Cho, D.K., Ultrasound-guided cannulation of the femoral vein for acute haemodialysis access. Nephrol Dial Transplant 12 (1997), 1009–1012.
161. Lin, B.S., Huang, T.P., Tang, G.J., et al. Ultrasound-guided cannulation of the internal jugular vein for dialysis vascular access in uremic patients. Nephron 78 (1998), 423–428.
162. Nadig, C., Leidig, M., Schmiedeke, T., et al. The use of ultrasound for the placement of dialysis catheters. Nephrol Dial Transplant 13 (1998), 978–981.
163. Zollo, A., Cavatorta, F., Galli, S., Ultrasound-guided cannulation of the femoral vein for acute hemodialysis access with silicone catheters. J Vasc Access 2 (2001), 56–59.
164. Schummer, W., Sakr, Y., Schummer, C., Towards optimal central venous catheter tip position. Intensive Care Medicine, In: Vincent J-L (ed)., 2008, Springer Verlag, Berlin, Germany, 581–590.
165. Vesely, T.M., Central venous catheter tip position: a continui ng controversy. J Vasc Interv Radiol 14 (2003), 527–534.
166. Hsu, J.H., Wang, C.K., Chu, K.S., et al. Comparison of radiographic landmarks and the echocardiographic SVC/RA junction in the positioning of long-term central venous catheters. Acta Anaesthesiol Scand 50 (2006), 731–735.
167. James, M.T., Conley, J., Tonelli, M., et al. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 148 (2008), 596–605.
168. Jaffer, Y., Selby, N.M., Taal, M.W., et al. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 51 (2008), 233–241.
169. Labriola, L., Crott, R., Jadoul, M., Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant 23 (2008), 1666–1672.
170. Yahav, D., Rozen-Zvi, B., Gafter-Gvili, A., et al. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47 (2008), 83–93.
171. Hackbarth, R., Bunchman, T.E., Chua, A.N., et al. The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRt registry. Int J Artif Organs 30 (2007), 1116–1121.
172. Bunchman, T.E., Brophy, P.D., Goldstein, S.L., Technical considerations for renal replacement therapy in children. Semin Nephrol 28 (2008), 488–492.
173. McDon ald, S.P., Craig, J.C., Long-term survival of children with end-stage renal disease. N Engl J Med 350 (2004), 2654–2662.
174. Chadha, V., Warady, B.A., Blowey, D.L., et al. Tenckhoff catheters prove superior to cook catheters in pediatric acute peritoneal dialysis. Am J Kidney Dis 35 (2000), 1111–1116.
175. Auron, A., Warady, B.A., Simon, S., et al. Use of the multipurpose drainage catheter for the provision of acute peritoneal dialysis in infants and children. Am J Kidney Dis 49 (2007), 650–655.
176. Modi, G.K., Pereira, B.J., Jaber, B.L., Hemodialysis in acute renal failure: does the membrane matter?. Semin Dial 14 (2001), 318–321.
177. Canivet, E., Lavaud, S., Wong, T., et al. Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis. Am J Kidney Dis 23 (1994), 41–46.
178. Marchant, A., Tielemans, C., Husson, C., et al. Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: role of complement activation. Nephrol Dial Transplant 11 (1996), 657–662.
179. Patarca, R., Perez, G., Gonzalez, A., et al. Comprehensive evaluation of acute immunological changes induced by cuprophane and polysulfone membranes in a patient on chronic hemodialysis. Am J Nephrol 12 (1992), 274–278.
180. Puentes, F., Pons, H., Rodriguez-Iturbe, B., Hemodialysis with cuprophane membranes is associated with a reduction in peripheral blood mononuclear cells expressing VLA-4 cell adhesion molecule. Clin Nephrol 42 (1994), 278–279.
181. Schaefer, R.M., Huber, L., Gilge, U., et al. Clinical evaluation of a new high-flux cellulose acetate membrane. Int J Artif Organs 12 (1989), 85–90.
182. Walker, R.J., Sutherland, W.H., De Jong, S.A., Effect of changing from a cellulose acetate to a polysulphone dialysis membrane on protein oxidation and inflammation markers. Clin Nephrol 61 (2004), 198–206.
183. Itoh, S., Susuki, C., Tsuji, T., Platelet activation through interaction with hemodialysis membranes induces neutrophils to produce reactive oxygen species. J Biomed Mater Res A 77 (2006), 294–303.
184. Hakim, R.M., Schafer, A.I., Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med 78 (1985), 575–580.
185. Sirolli, V., Strizzi, L., Di Stante, S., et al. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. Thromb Haemost 86 (2001), 834–839.
186. Takeshita, K., Susuki, C., Itoh, S., et al. Preventive effect of alpha-tocopherol and glycyrrhizin against platelet -neutrophil complex formation induced by hemodialysis membranes. Int J Artif Organs 32 (2009), 282–290.
187. Alonso, A., Lau, J., Jaber, B.L., Biocompatible hemodialysis membranes for acute renal failure. Cochrane Database Syst Rev, 2008, CD005283.
188. Brophy, P.D., Mottes, T.A., Kudelka, T.L., et al. AN-69 membrane reactions are pH-dependent and preventable. Am J Kidney Dis 38 (2001), 173–178.
189. Hackbarth, R.M., Eding, D., Gianoli Smith, C., et al. Zero balance ultrafiltration (Z-BUF) in blood-primed CRRT circuits achieves electrolyte and acid-base homeostasis prior to patient connection. Pediatr Nephrol 20 (2005), 1328–1333.
190. Pasko, D.A., Mottes, T.A., Mueller, B.A., Pre dialysis of blood prime in continuous hemodialysis normalizes pH and electrolytes. Pediatr Nephrol 18 (2003), 1177–1183.
191. Perez-Garcia, R., Galan, A., Garcia Vinuesa, M., et al. Anaphylactoid reactions during hemodialysis on AN69 membranes: role of ACE inhibitors and back-filtration. Nephron, 61, 1992, 123.
192. Petrie, J.J., Campbell, Y., Hawley, C.M., et al. Anaphylactoid reactions in patients on hemodiafiltration with AN69 membranes whilst receiving ACE inhibitors. Clin Nephrol 36 (1991), 264–265.
193. Tielemans, C., Madhoun, P., Lenaers, M., et al. Anaphylactoid reactions during hemodialysi s on AN69 membranes in patients receiving ACE inhibitors. Kidney Int 38 (1990), 982–984.
194. Desormeaux, A., Moreau, M.E., Lepage, Y., et al. The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes. Biomaterials 29 (2008), 1139–1146.
195. RENAL Study Investigators, Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey. Crit Care Resusc 10 (2008), 225–230.
196. Gatward, J.J., Gibbon, G.J., Wrathall, G., et al. Renal replacement therapy for acute renal failure: a survey of practice in adult intensive care units in the United Kingdom. Anaesthesia 63 (2008), 959–966.
197. Langford, S., Slivar, S., Tucker, S.M., et al. Exploring CRRT practices in ICU: a survey of Canadian hospitals. Dynamics 19 (2008), 18–23.
198. Rabindranath, K., Adams, J., Macleod, A.M., et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev, 2007, CD003773.
199. Bagshaw, S.M., Berthiaume, L.R., Delaney, A., et al. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med 36 (2008), 610–617.
200. Pan nu, N., Klarenbach, S., Wiebe, N., et al. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA 299 (2008), 793–805.
201. Lins, R.L., Elseviers, M.M., Van der Niepen, P., et al. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol Dial Transplant 24 (2009), 512–518.
202. Farese, S., Jakob, S.M., Kalicki, R., et al. Treatment of acute renal failure in the intensive care unit: lower costs by intermittent dialysis than continuous venovenous hemodiafiltration. Artif Organs 33 (2009), 634–640.
203. Klarenbach, S., Manns, B., Pannu, N., et al. Economic evaluation of continuous renal replacement therapy in acute renal failure. Int J Technol Assess Health Care 25 (2009), 331–338.
204. Srisawat, N., Lawsin, L., Uchino, S., et al. Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Crit Care, 14, 2010, R46.
205. Bell, M., Granath, F., Schon, S., et al. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med 33 (2007), 773–780.
206. Jacka, M.J., Ivancinova, X., Gibney, R.T., Continuous renal replacement therapy improves renal recovery from acute renal failure. Can J Anaesth 52 (2005), 327–332.
207. Uchino, S., Bellomo, R., Kellum, J.A., et al. Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs 30 (2007), 281–292.
208. Kielstein, J.T., Schiffer, M., Hafer, C., Back to the future: extended dialysis for treatment of acute kidney injury in the intensive care unit. J Nephrol 23 (2010), 494–501.
209. Kielstein, J.T., Kretschmer, U., Ernst, T., et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 43 (2004), 342–349.
210. Baldwin, I., Bellomo, R., Naka, T., et al. A pilot randomized controlled comparison of extended daily dialysis with filtration and continuous veno-venous hemofiltration: fluid removal and hemodynamics. Int J Artif Organs 30 (2007), 1083–1089.
211. Baldwin, I., Naka, T., Koch, B., et al. A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance. Intensive Care Med 33 (2007), 830–835.
212. Marshall, M.R., Creamer, J.M., Foster, M., et al. Mortality rate comparison after switching from continuous to prolonged intermittent renal replacement for acute kidney injury in three intensive care units from different countries. Nephrol Dial Transplant 26 (2011), 2169–2175.
213. Fieghen, H.E., Friedrich, J.O., Burns, K.E., et al. The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury. BMC Nephrol, 11, 2010, 32.
214. Davenport, A., Continuous renal replacement therapies in patients with acute neurological injury. Semin Dial 22 (2009), 165–168.
215. Bagshaw, S.M., Peets, A.D., Hameed, M., et al. Dialysis Disequilibrium Syndrome: brain death following hemodialysis for metabolic acidosis and acute renal failure–a case report. BMC Nephrol, 5, 2004, 9.
216. Lin, C.M., Lin, J.W., Tsai, J.T., et al. Intracran ial pressure fluctuation during hemodialysis in renal failure patients with intracranial hemorrhage. Acta Neurochir Suppl 101 (2008), 141–144.
217. Ronco, C., Bellomo, R., Brendolan, A., et al. Brain density changes during renal replacement in critically ill patients with acute renal failure. Continuous hemofiltration versus intermittent hemodialysis. J Nephrol 12 (1999), 173–178.
218. Paganini, E.P., Sandy, D., Moreno, L., et al. The effect of sodium and ultrafiltration modelling on plasma volume changes and haemodynamic stability in intensive care patients receiving haemodialysis for acute renal failure: a prospective, stratified, randomized, cross-over study. Nephrol Dial Transplant 11:Suppl 8 (1996), 32–37.
219. Schortgen, F., Soubrier, N., Delclaux, C., et al. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines. Am J Respir Crit Care Med 162 (2000), 197–202.
220. Bargman, J.M., New technologies in peritoneal dialysis. Clin J Am Soc Nephrol 2 (2007), 576–580.
221. Chionh, C.Y., Soni, S., Cruz, D.N., et al. Peritoneal dialysis for acute kidney injury: techniques and dose. Contrib Nephrol 163 (2009), 278–284.
222. Ronco, C., Amerling, R., Continuous flow peritoneal dialysis: current state-of-the-art and obstacles to further development. Contrib Nephrol 150 (2006), 310–320.
223. Phu, N.H., Hien, T.T., Mai, N.T., et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 347 (2002), 895–902.
224. Gabriel, D.P., Caramori, J.T., Martim, L.C., et al. High volume peritoneal dialysis vs daily hemodialysis: a randomized, controlled trial in patients with acute kidney injury. Kidney Int Suppl, 2008, S87–S93.
225. Vachvanichsanong, P., Dissaneewate, P., Lim, A., et al. Childhood acute renal failure: 22-year experience in a university hospital in southern Thailand. Pediatrics 118 (2006), e786–e791.
226. Bailey, D., Phan, V., Litalien, C., et al. Risk factors of acute renal failure in critically ill children: A prospective descriptive epidemiological study. Pediatr Crit Care Med 8 (2007), 29–35.
227. Bunchman, T.E., Maxvold, N.J., Kershaw, D.B., et al. Continuous venovenous hemodiafiltration in infants and children. Am J Kidney Dis 25 (1995), 17–21.
228. Sadowski, R.H., Harmon, W.E., Jabs, K., Acute hemodialysis of infants weighing less than five kilograms. Kidney Int 45 (1994), 903–906.
229. Symons, J.M., Brophy, P.D., Gregory, M.J., et al. Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis 41 (2003), 984–989.
230. Warady, B.A., Bunchman, T., Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol 15 (2000), 11–13.
231. Bunchman, T.E., McBryde, K.D., Mottes, T.E., et al. Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol 16 (2001), 1067–1071.
232. Flores, F.X., Brophy, P.D., Symons, J.M., et al. Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol 23 (2008), 625–630.
233. Noris, M., Todeschini, M., Casiraghi, F., et al. Effect of acetate, bicarbonate dialysis, and acetate-free biofiltration on nitric oxide synthesis: implications for dialysis hypotension. Am J Kidney Dis 32 (1998), 115–124.
234. Levraut, J., Ichai, C., Petit, I., et al. Low exogenous lactate clearance as an early predictor of mortality in normolactatemic critically ill septic patients. Crit Care Med 31 (2003), 705–710.
235. Veech, R.L., The untoward effects of the anions of dialysis fluids. Kidn ey Int 34 (1988), 587–597.
236. Barenbrock, M., Hausberg, M., Matzkies, F., et al. Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 58 (2000), 1751–1757.
237. McLean, A.G., Davenport, A., Cox, D., et al. Effects of lactate-buffered and lactate-free dialysate in CAVHd patients with and without liver dysfunction. Kidney Int 58 (2000), 1765–1772.
238. Thomas, A.N., Guy, J.M., Kishen, R., et al. Comparison of lactate and bicarbon ate buffered haemofiltration fluids: use in critically ill patients. Nephrol Dial Transplant 12 (1997), 1212–1217.
239. Tan, H.K., Uchino, S., Bellomo, R., The acid-base effects of continuous hemofiltration with lactate or bicarbonate buffered replacement fluids. Int J Artif Organs 26 (2003), 477–483.
240. Zimmerman, D., Cotman, P., Ting, R., et al. Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: prospective cross-over comparison with a lactate buffered solution. Nephrol Dial Transplant 14 (1999), 2387–2391.
241. Holloway, P., Benham, S., St John, A., The value of blood lactate measurements in ICU: an evaluation of the role in the managemen t of patients on haemofiltration. Clin Chim Acta 307 (2001), 9–13.
242. Ledebo, I., On-line preparation of solutions for dialysis: practical aspects versus safety and regulations. J Am Soc Nephrol 13:Suppl 1 (2002), S78–S83.
243. Marshall, M.R., Ma, T., Galler, D., et al. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant 19 (2004), 877–884.
244. Ronco, C., Backfiltration in clinical dialysis: nature of the phenomenon, mechanisms and possible solutions. Int J Artif Organs 13 (1990), 11–21.
245. Kanagasundaram, N.S., Larive, A.B., Paganini, E.P., A preliminary survey of bacterial contamination of the dialysate circuit in continuous veno-venous hemodialysis. Clin Nephrol 59 (2003), 47–55.
246. Moore, I., Bhat, R., Hoenich, N.A., et al. A microbiological survey of bicarbonate-based replacement circuits in continuous veno-venous hemofiltration. Crit Care Med 37 (2009), 496–500.
247. Ward, R.A., Worldwide guidelines for the preparation and quality management of dialysis fluid and their implementation. Blood Purif 27:Suppl 1 (2009), 2–4.
248. Association for the Advancement of Medical Instrumentation, Water for Hemodialysis and Related Therapies, ANSI/AAMI/ISO 13959:2009., 2010, AAMI, Arlington, VA.
249. Association for the Advancement of Medical Instrumentation, Concentrates for Hemodialysis and Related Therapies, ANSI/AAMI/ISO 13958:2009., 2011, AAMI, Arlington, VA.
250. Association for the Advancement of Medical Instrumentation, Quality of Dialysis Fluid for Hemodialysis and Related Therapies, ANSI/AAMI/ISO 11663:2009., 2010, AAMI, Arlington, VA.
251. European best practice guidelines for haemodialys is (Part 1). Section IV: Dialysis fluid purity. Nephrol Dial Transplant 17:Suppl (2002), 45–62.
252. Kolff, W.J., First clinical experience with the artificial kidney. Ann Intern Med 62 (1965), 608–619.
253. Davenport, A., Bouman, C., Kirpalani, A., et al. Delivery of renal replacement therapy in acute kidney injury: what are the key issues?. Clin J Am Soc Nephrol 3 (2008), 869–875.
254. Faulhaber-Walter, R., Hafer, C., Jahr, N., et al. The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant 24 (2009), 2179–2186.
255. Ronco, C., Bellomo, R., Homel, P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356 (2000), 26–30.
256. Saudan, P., Niederberger, M., De Seigneux, S., et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70 (2006), 1312–1317.
257. Schiffl, H., Lang, S.M., Fischer, R., Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346 (2002), 305–310.
258. Tolwani, A.J., Campbell, R.C., Stofan, B.S., et al. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 19 (2008), 1233–1238.
259. Paganini, E.P., Tapolyai, M., Goormastic, M., et al. Establishing a dialysis therapy/pat ient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am J Kidney Dis 28:Suppl 3 (1996), S81–S89.
260. Ricci, Z., Ronco, C., D'Amico, G., et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant 21 (2006), 690–696.
261. Ikizler, T.A., Sezer, M.T., Flakoll, P.J., et al. Urea space and total body water measurements by stable isotopes in patients with acute renal failure. Kidney Int 65 (2004), 725–732.
262. Evanson, J.A., Ikizler, T.A., Wingard, R., et al. Measurement of the delivery of dialysis in acute renal failure. Kidney Int 55 (1999), 1501–1508.
263. Evanson, J.A., Himmelfarb, J., Wingard, R., et al. Prescribed versus delivered dialysis in acute renal failure patients. Am J Kidney Dis 32 (1998), 731–738.
264. Schiffl, H., Disease severity adversely affects delivery of dialysis in acute renal failure. Nephron Clin Pract 107 (2007), c163–c169.
265. Gotch, F.A., Sargent, J.A., A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28 (1985), 526–534.
266. Held, P.J., Port, F.K., Wolfe, R.A., et al. The dose of hemodialysis and patient mortality. Kidney Int 50 (1996), 550–556.
267. Eknoyan, G., Beck, G.J., Cheung, A.K., et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347 (2002), 2010–2019.
268. Venkataraman, R., Kellum, J.A., Palevsky, P., Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States. J Crit Care 17 (2002), 246–250.
269. Boussekey, N., Chiche, A., Faure, K., et al. A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 34 (2008), 1646–1653.